Zacks Investment Research on MSN
10x Genomics, Cleveland Clinic team up on bladder cancer diagnostics
10x Genomics TXG recently entered into a multi-year research collaboration with the Cleveland Clinic to advance novel ...
NT-proBNP is one of the most widely used tested biomarkers in medicine. Doctors rely on it to diagnose and monitor heart ...
EndoDNA Launches BIOS, Turning Genetic Data Into Living Clinical Intelligence for Precision Medicine
BIOS, short for Biomedical Reasoning and Adaptive Inference Network, moves precision medicine past static, one-time genetic reports. In their place, it provides an adaptive dashboard that brings ...
Leading Alzheimer's Disease Researcher Joins to Advance Circular RNA Blood-Based Biomarker Platform for Neurodegenerative Diseases SAN DIEGO, April 24, 2026 /PRNewswire/ -- Circular Genomics, a ...
The European Medicines Agency (EMA) has released a new draft guideline intended to leverage pharmacogenomics in tracking and evaluating adverse events in products once they have received approval.
Precision medicine is rapidly expanding the range of biological signals that can be measured in clinical practice. Advances in genomics, epigenomics, and multi omics technologies now allow clinicians ...
Advanced deep learning (DL) and large language models (LLMs) decode multimodal imaging-omics associations across modalities, scales, organs, and diseases. The framework enables interpretable analysis ...
NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ('Aptorum Group” or ...
Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical data ...
Workflow of combined biomarker and genetic newborn screening. This schematic illustrates the integrated framework for neonatal combined screening, linking disease and gene selection with standardized ...
A four-pronged approach to CV risk assessment that integrates genomics with lipid and inflammatory biomarkers tested in midlife is predictive of future coronary artery disease, new data from the UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results